rs142056835
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The ENST00000320785.10(KIF1C):c.1111G>A(p.Ala371Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00426 in 1,614,248 control chromosomes in the GnomAD database, including 20 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
ENST00000320785.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KIF1C | NM_006612.6 | c.1111G>A | p.Ala371Thr | missense_variant | 13/23 | ENST00000320785.10 | NP_006603.2 | |
KIF1C | XM_005256424.3 | c.1111G>A | p.Ala371Thr | missense_variant | 14/24 | XP_005256481.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KIF1C | ENST00000320785.10 | c.1111G>A | p.Ala371Thr | missense_variant | 13/23 | 1 | NM_006612.6 | ENSP00000320821 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00355 AC: 541AN: 152250Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.00337 AC: 847AN: 251406Hom.: 1 AF XY: 0.00327 AC XY: 444AN XY: 135882
GnomAD4 exome AF: 0.00434 AC: 6342AN: 1461880Hom.: 19 Cov.: 32 AF XY: 0.00428 AC XY: 3109AN XY: 727238
GnomAD4 genome AF: 0.00355 AC: 541AN: 152368Hom.: 1 Cov.: 32 AF XY: 0.00360 AC XY: 268AN XY: 74516
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | research | Unit for Genetic & Epidemiological Research on Neurological Disorders, Instituto de Investigação e Inovação em Saúde | Mar 07, 2017 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Mar 29, 2021 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 27, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Spastic ataxia 2 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2024 | KIF1C: BS2 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at